Triptolide Modulates TREM-1 Signal Pathway to Inhibit the Inflammatory Response in Rheumatoid Arthritis

Triptolide (TP), an active component isolated from Tripterygiumwilfordii Hook F, has therapeutic potential against rheumatoid arthritis (RA). However, the underlying molecular mechanism has not been fully elucidated. The aim of this study is to investigate the mechanisms of TP acting on RA by combining bioinformatics analysis with experiment validation. The human protein targets of TP and the human genes of RA were found in the PubChem database and NCBI, respectively. These two dataset were then imported into Ingenuity Pathway Analysis (IPA) software online, and then the molecular network of TP on RA could be set up and analyzed. After that, both in vitro and in vivo experiments were done to further verify the prediction. The results indicated that the main canonical signal pathways of TP protein targets networks were mainly centered on cytokine and cellular immune signaling, and triggering receptors expressed on myeloid cells (TREM)-1 signaling was searched to be the top one shared signaling pathway and involved in the cytokine and cellular immune signaling. Further in vitro experiments indicated that TP not only remarkably lowered the levels of TREM-1 and DNAX-associated protein (DAP)12, but also significantly suppressed the activation of janus activating kinase (JAK)2 and signal transducers and activators of transcription (STAT)3. The expression of tumor necrosis factor (TNF)-α, interleukin (IL)-1β and IL-6 in lipopolysaccharides (LPS)-stimulated U937 cells also decreased after treatment with TP. Furthermore, TREM-1 knockdown was able to interfere with the inhibition effects of TP on these cytokines production. In vivo experiments showed that TP not only significantly inhibited the TREM-1 mRNA and DAP12 mRNA expression, and activation of JAK2 and STAT3 in ankle of rats with collagen-induced arthritis (CIA), but also remarkably decreased production of TNF-α, IL-1β and IL-6 in serum and joint. These findings demonstrated that TP could modulate the TREM1 signal pathway to inhibit the inflammatory response in RA.

[1]  C. Buonsanti,et al.  A Role for Triggering Receptor Expressed on Myeloid Cells-1 in Host Defense During the Early-Induced and Adaptive Phases of the Immune Response1 , 2003, The Journal of Immunology.

[2]  P. Lipsky,et al.  Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription. , 2004, Arthritis and rheumatism.

[3]  M. DePamphilis,et al.  HUMAN DISEASE , 1957, The Ulster Medical Journal.

[4]  F. Massin,et al.  Elevated synovial expression of triggering receptor expressed on myeloid cells 1 in patients with septic arthritis or rheumatoid arthritis , 2008, Annals of the rheumatic diseases.

[5]  G R Burmester,et al.  Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis? , 1997, Arthritis and rheumatism.

[6]  M. Feldmann,et al.  TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokines. , 2009, Rheumatology.

[7]  A. Koch,et al.  Angiogenesis as a target in rheumatoid arthritis , 2003, Annals of the rheumatic diseases.

[8]  M. Ernst,et al.  Interleukin‐15 stimulates macrophages to activate CD4+ T cells: a role in the pathogenesis of rheumatoid arthritis? , 2009, Immunology.

[9]  A. Cerwenka,et al.  The TREM-1/DAP12 pathway. , 2008, Immunology letters.

[10]  A. Lu,et al.  Effects of triptolide from Radix Tripterygium wilfordii (Leigongteng) on cartilage cytokines and transcription factor NF-κB: a study on induced arthritis in rats , 2009, Chinese medicine.

[11]  J. Thumboo,et al.  In vivo pro- and anti-inflammatory cytokines in normal and patients with rheumatoid arthritis. , 2007, Annals of the Academy of Medicine, Singapore.

[12]  R. Flavell,et al.  Endothelial Cells Require STAT3 for Protection against Endotoxin-induced Inf lammation , 2003, The Journal of experimental medicine.

[13]  M. Ornatowska,et al.  Functional genomics of silencing TREM-1 on TLR4 signaling in macrophages. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[14]  P. Lipsky,et al.  A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis. , 2001, The Journal of rheumatology.

[15]  Nicodemus Tedla,et al.  Suppression of vascular permeability and inflammation by targeting of the transcription factor c-Jun , 2006, Nature Biotechnology.

[16]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[17]  H. Nie,et al.  Exogenous IFN-beta regulates the RANKL-c-Fos-IFN-beta signaling pathway in the collagen antibody-induced arthritis model , 2014, Journal of Translational Medicine.

[18]  S. Akira,et al.  Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. , 1999, Immunity.

[19]  Y. Ha,et al.  Levels of Plasma-soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) Are Correlated with Disease Activity in Rheumatoid Arthritis , 2012, The Journal of Rheumatology.

[20]  John D. Storey,et al.  A network-based analysis of systemic inflammation in humans , 2005, Nature.

[21]  J. Darnell.  STATs and gene regulation. , 1997, Science.

[22]  L. Joosten,et al.  TREM‐1: intracellular signaling pathways and interaction with pattern recognition receptors , 2013, Journal of leukocyte biology.

[23]  L. Klareskog,et al.  Appearance of Different Lymphoid Cells in Synovial Tissue and in Peripheral Blood during the Course of Collagen II‐Induced Arthritis in Rats , 1985, Scandinavian journal of immunology.

[24]  K. Onozaki.  Etiological and biological aspects of cigarette smoking in rheumatoid arthritis. , 2009, Inflammation & allergy drug targets.

[25]  J. Frazier,et al.  Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data. , 1999, Arthritis and rheumatism.

[26]  I. Raskin,et al.  MyD88-dependent and independent pathways of Toll-Like Receptors are engaged in biological activity of Triptolide in ligand-stimulated macrophages , 2010, BMC chemical biology.

[27]  Wan-Uk Kim,et al.  Soluble Fas ligand inhibits angiogenesis in rheumatoid arthritis , 2007, Arthritis research & therapy.

[28]  M. Colonna,et al.  Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and Monocytes1 , 2000, The Journal of Immunology.

[29]  J. Zwerina,et al.  Pathogenesis of Rheumatoid Arthritis: Targeting Cytokines , 2005, Annals of the New York Academy of Sciences.

[30]  S. Banerjee,et al.  Inhibition of type II collagen induced arthritis in mice by an immunosuppressive extract of Tripterygium wilfordii Hook f. , 1992, The Journal of rheumatology.

[31]  C. Gilmore,et al.  Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii. , 1972, Journal of the American Chemical Society.

[32]  K. Asano,et al.  Suppressive effects of Tripterygium wilfordii Hook f., a traditional Chinese medicine, on collagen arthritis in mice. , 1998, Immunopharmacology.

[33]  R. Holmdahl,et al.  Immunogenetics of type II collagen autoimmunity and susceptibility to collagen arthritis. , 1988, Immunology.

[34]  E. Remmers,et al.  The non-major histocompatibility complex quantitative trait locus Cia10 contains a major arthritis gene and regulates disease severity, pannus formation, and joint damage. , 2005, Arthritis and rheumatism.

[35]  L. Davis,et al.  Effect of an extract of the Chinese herbal remedy Tripterygium wilfordii Hook F on human immune responsiveness. , 1991, Arthritis and rheumatism.

[36]  D. Yew,et al.  Triptolide Down‐regulates COX‐2 Expression and PGE2 Release by Suppressing the Activity of NF‐κB and MAP kinases in Lipopolysaccharide‐treated PC12 Cells , 2011, Phytotherapy research : PTR.

[37]  Lei Feng,et al.  [Effect of Triptolide on TNFalpha-induced activation of NF-kappaB and expression of COX-2 and iNOS in human rheumatoid arthritis synovial fibroblasts]. , 2004, Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences.

[38]  V. Reutrakul,et al.  Antitumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamsters. , 1998, Cancer letters.

[39]  F. Seibold,et al.  TREM-1--expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. , 2007, The Journal of clinical investigation.

[40]  Yuanyuan Wu,et al.  Triptolide attenuates oxidative stress, NF-kappaB activation and multiple cytokine gene expression in murine peritoneal macrophage. , 2006, International journal of molecular medicine.

[41]  O. Lesur,et al.  Effects of TREM-1 activation in human neutrophils: activation of signaling pathways, recruitment into lipid rafts and association with TLR4. , 2006, International immunology.

[42]  A. Koch.  Chemokines in Rheumatoid Arthritis , 1999, Springer seminars in immunopathology.